Associate Professor, Medicine-Hematology, University of Tennessee Health Science Center College of Medicine
Oncology
Dr. Kurt W. Tauer, MD
|
|
Give Review
Kurt Tauer practices Oncology. He went to medical school at Saint Louis University School of Medicine. Saint Louis University School of Medicine is ranked 67 in research and 57 in primary care medicine He received awards:"Physician Practice Connections Recognition Program", "Fellow (FACP)" and "Top MD". Kurt W. Tauer, MD is also a published MD. He has 20 publication published. The most recent publication is: Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient adminis... He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors.
- Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2-Negative Advanced Breast Cancer That Progressed during or after Bevacizumab.
- For love of the profession. Kurt W. Tauer--Physician Executive of the Year Award.
- Experiencing neutropenia: quality of life interviews with adult Cancer patients.
- Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities.
- The Zero Acceptance of Pain (ZAP) Quality Improvement Project: evaluation of pain severity, pain interference, global quality of life, and pain-related costs.
- The Cancer Care Monitor: psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult Cancer ...
- Impact of chemotherapy-induced neutropenia on quality of life: a prospective pilot investigation.
- Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon Cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
- Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast Cancer: outpatient adminis...
- Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast Cancer with five to nine involved axillary lymph nodes.
- Peripheral blood stem Cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
- LAK Cell therapy--clinical studies and future potential.
- Rapid and sustained hematopoietic reconstitution by peripheral blood stem Cell infusion alone following high-dose chemotherapy.
- Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem Cells with a low CD34+ Cell content.
- High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin''s lymphoma: results of outpatient treatment in community Cancer centers.
- A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem Cells in 318 patients with stage II-III breast c...
- Second attempts at mobilization of peripheral blood stem Cells in patients with initial low CD34+ Cell yields.
- High-dose chemotherapy with peripheral blood stem Cell support for stage IIIB inflammatory carcinoma of the breast.
Schools
Saint Louis University School Of Medicine
Baptist Memorial Hospital Memphis
Meml Sloan Kettering Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Physician Practice Connections Recognition Program
- Fellow (FACP)
- Top MD
Education
-
Memorial Sloan-Kettering Cancer Center -
Saint Louis University School of Medicine
Hospital
-
University of Tennessee Medical Center
Drug Facts
| NPI NUMBER | 1053340802 | |
| NPPES Provider LastName | TAUER | |
| NPPES Provider FirstName | KURT | |
| NPPES Provider ZIPCode | 381202146 | |
| NPPES Provider State | TN | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 3457.0 | |
| Distinct Opioid Count | 8.0 | |
| Opioid Claim Count | 348.0 | |
| Percent Opioid Claims | 10.07 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1053340802 |
| Last Name Of The Provider | TAUER |
| First Name Of The Provider | KURT |
| View All |
Similar Doctors
|
Dr. Suhail Obaji, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Albert E. Weeks, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lee S. Schwartzberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Sylvia S. Richey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Roy C. Page, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Bradley G. Somer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ari M. Vanderwalde, MD
This Doctor is OpenDoctor Recommended.
|